Sort

Search

01/01/2023 Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT
Benito N., Martínez-Pastor J.C., Lora-Tamayo J., Ariza J., Baeza J., Belzunegui-Otano J., Cobo J., del-Toro M.-D., Fontecha C.G., Font-Vizcarra L., Horcajada J.P., Morata L., Murillo O., Nolla J.M., Núñez-Cuadros E., Pigrau C., Portillo M.E., Rodríguez-Pardo D., Sobrino-Díaz B., Saavedra-Lozano J.. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; DOI:10.1016/j.eimc.2023.07.003. PMID:. IF:(Q/D).
01/01/2023 Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis
Sainz L., Riera P., Moya P., Bernal S., Casademont J., Díaz-Torné C., Millán A.M., Park H.S., Lasa A., Corominas H.. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1)DOI:10.3390/jpm13010061. PMID:36675722. IF:3.000(Q1/2D).
01/01/2023 The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Colalillo A., Hoffmann-Vold A.-M., Pellicano C., Romaniello A., Gabrielli A., Hachulla E., Smith V., Simeón-Aznar C.-P., Castellví I., Airò P., Truchetet M.-E., Siegert E., Distler O., Rosato E.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4)DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9.200(Q1/1D).
01/01/2023 Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Tasende J.A.P., Baute J.J.B., Joven Ibáñez B., Toniolo E., Ramírez J., Montero N., Pruenza García-Hinojosa C., Serrano García A.. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12030931. PMID:36769579. IF:3.000(Q1/2D).
01/01/2023 Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
Jeria-Navarro S., Gomez-Gomez A., Park H.S., Calvo-Aranda E., Corominas H., Pou M.A., Diaz-Torne C.. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3.100(Q1/2D).
01/01/2023 Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Narváez J., Aburto M., Seoane-Mato D., Bonilla G., Acosta O., Candelas G., Cano-Jiménez E., Castellví I., González-Ruiz J.M., Corominas H., López-Muñiz B., Martín-López M., Robles-Pérez A., Mena-Vázquez N., Rodríguez-Portal J.A., Ortiz A.M., Sabater-Abad C., Castrejón I., dos Santos R., Garrote-Corral S., Maese J., Silva-Fernández L., Castañeda S., Valenzuela C.. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2)DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:(Q/D).
01/01/2023 Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., Marcos A.G.. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1)DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3.400(Q2/3D).
01/01/2023 Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis
Oteo J.A., Corominas H., Escudero R., Fariñas-Guerrero F., García-Moncó J.C., Goenaga M.A., Guillén S., Mascaró J.M., Portillo A.. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1)DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2.600(Q3/6D).
01/01/2023 Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Crespo-Lessmann A., Curto E., Medina, EFM, Palones E., Soler A.B., Maza S.S., Soto-Retes L., Plaza V.. Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S389402. PMID:36699564. IF:3.700(Q1/3D).
01/01/2023 Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
Molina J., Plaza V., Nuevo J., Gutiérrez M., Sicras-Mainar A., Valero A.. Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100232. PMID:37496866. IF:(Q/D).
01/01/2023 Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
Plaza V., Cañete C., Domingo C., Martínez Rivera C., Muñoz X.. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2022.100231. PMID:37496871. IF:(Q/D).
01/01/2023 Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
Barroso B., Valverde-Monge M., Alobid I., Olaguibel J.M., Rial M.J., Quirce S., Arismendi E., Barranco P., Betancor D., Bobolea I., Cárdaba B., Cruz Carmona M.J., Curto E., Domínguez-Ortega J., González-Barcala F.J., Martínez-Rivera C., Mahíllo-Fernández I., Muñoz X., Picado C., Plaza V., Rodrigo Muñoz J.M., Soto-Retes L., Valero A., Del Pozo V., Mullol J., Sastre J.. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0812. PMID:35416154. IF:6.700(Q1/2D).
01/01/2023 Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Pérez de Llano L., Cisneros C., Domínguez-Ortega J., Martínez-Moragón E., Olaguibel J.M., Plaza V., Quirce S., Dávila I.. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0857. PMID:36040046. IF:6.700(Q1/2D).
01/01/2023 Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
Gil-Martínez M., Lorente-Sorolla C., Rodrigo-Muñoz J.M., Lendínez M.Á., Núñez-Moreno G., de la Fuente L., Mínguez P., Mahíllo-Fernández I., Sastre J., Valverde-Monge M., Quirce S., Caballero M.L., González-Barcala F.J., Arismendi E., Bobolea I., Valero A., Muñoz X., Cruz M.J., Martínez-Rivera C., Plaza V., Olaguibel J.M., del Pozo V.. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(2)DOI:10.3390/ijms24021611. PMID:36675122. IF:4.900(Q1/3D).
01/01/2023 Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(1)DOI:10.1016/j.arbres.2022.07.011. PMID:35970652. IF:8.700(Q1/1D).
01/01/2023 Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain
Valero A., Molina J., Nuevo J., Simon S., Capel M., Sicras-Mainar A., Sicras-Navarro A., Plaza V.. Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(2)DOI:10.18176/jiaci.0767. PMID:34825651. IF:6.700(Q1/2D).
01/01/2023 Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Domínguez-Ortega J., Luna-Porta J.A., Olaguibel J.M., Barranco P., Arismendi E., Barroso B., Betancor D., Bobolea I., Caballero M.L., Cárdaba B., Cruz M.J., Curto E., González-Barcala F.J., Losantos-García I., Martínez-Rivera C., Mendez-Brea P., Mullol J., Munoz, X, Picado C., Plaza V., Del Pozo V., Rial M.J., Sastre J., Soto L., Valero A., Valverde-Monge M., Quirce S.. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(4)DOI:10.18176/jiaci.0816. PMID:35503227. IF:6.700(Q1/2D).
01/01/2023 Factors Associated With Large Airway Collapse in Severe Asthma
Martinez Rivera C., Serra Mitjà P., Andreo García F., Crespo-Lessmann A., Solis Solis A.J., Torrego A., Garcia-Olive I., Ramos-Barbón D., Zapata Comas T., Plaza V., Abad J., Rosell A.. Factors Associated With Large Airway Collapse in Severe Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(9)DOI:10.1016/j.arbres.2023.05.006. PMID:37296031. IF:8.700(Q1/1D).
01/01/2023 Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis
Cobo Sanchez L., Ruiz Herrero C., Cobos I., Bespin J., Gadea C., Cerdá-Cortés P., Palma J., Vicens-Zygmunt V., Bermudo G., Portillo K., Boldova A., Robles A., Arribas J., Figuerola J.A., Blavia R., Moreno A., Castillo D., Villar A., Belmonte Y., Badenes-Bonet D., Zayas D., Suarez-Cuartin G., Garcia-Bellmunt L., Sellarés J., Barril S., Sans J., Serra M., Perich D., Esteban L.L., Esteban L., Balcells E., Gil F., Ruiz E., Fina C., Molina-Molina M.. Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8)DOI:10.1016/j.arbres.2023.03.008. PMID:37003881. IF:8.700(Q1/1D).
01/01/2023 A Study of the Prevalence of Asthma in the General Population in Spain
Blanco-Aparicio M., García-Río F.J., González-Barcala F.J., Jiménez-Ruiz C.A., Muñoz X., Plaza V., Soto-Campos J.G., Urrutia-Landa I., Almonacid C., Peces-Barba G., Álvarez-Gutiérrez F.J.. A Study of the Prevalence of Asthma in the General Population in Spain. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100245. PMID:37496876. IF:(Q/D).